CNTA DCF Valuation - Centessa Pharmaceuticals PLC

Watchlist Manager

Watchlist

Price: 39.86 USD 0.35% Market Closed

Market Cap: $5.3B

	Centessa Pharmaceuticals PLC NASDAQ:CNTA	UK
C	CS Corp KOSDAQ:065770	KR
	Suzuki Co Ltd TSE:6785	JP
	Nihon ISK Co Ltd TSE:7986	JP
	Wallbridge Mining Company Ltd TSX:WM	CA
	GEM Co Ltd SZSE:002340	CN
	Shield On Service Tbk PT IDX:SOSS	ID
N	Nahar Spinning Mills Ltd NSE:NAHARSPING	IN
S	Super Group Ltd XBER:S8G1	ZA
	Palantir Technologies Inc NASDAQ:PLTR	US
	TWFG Inc NASDAQ:TWFG	US
	Norzinc Ltd TSX:NZC	CA
	FD Technologies PLC LSE:FDP	UK
S	Silo Pharma Inc NASDAQ:SILO	US
V	Virax Biolabs Group Ltd NASDAQ:VRAX	UK
	LPP SA WSE:LPP	PL
S	SensOre Ltd. ASX:S3N	AU
B	Bougainville Copper Ltd ASX:BOC	PG
	Intact Financial Corp TSX:IFC	CA
O	OssDsign AB STO:OSSD	SE
	Guess? Inc NYSE:GES	US
N	Nocera Inc NASDAQ:NCRA	US
V	Vee SA WSE:VEE	PL
K	Kayne Anderson BDC Inc NYSE:KBDC	US

CNTA's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.